16/05/2022
Published by Fondazione Gianni Bonadonna at 16/05/2022
Categories

Safety and activity of the selective FGFR 1-3 inhibitor pemigatinib

Do you like it?0
Read more
09/05/2022
Published by Fondazione Gianni Bonadonna at 09/05/2022
Categories

Breast tumor microenvironment structures are associated with clinical outcomes

Do you like it?0
Read more
02/05/2022
Published by Fondazione Gianni Bonadonna at 02/05/2022
Categories

A new screening platform to discover novel KRAS inhibitors

Do you like it?0
Read more
25/04/2022
Published by Fondazione Gianni Bonadonna at 25/04/2022
Categories

A novel approach to target enhancer-addicted cancers

Do you like it?0
Read more
18/04/2022
Published by Fondazione Gianni Bonadonna at 18/04/2022
Categories

Pro-tumorigenic mechanisms of leukaemia

Do you like it?0
Read more
11/04/2022
Published by Fondazione Gianni Bonadonna at 11/04/2022
Categories

Pyrotinib plus capecitabine in breast cancer with brain metastases

Do you like it?0
Read more
04/04/2022
Published by Fondazione Gianni Bonadonna at 04/04/2022
Categories

Lenvatinib and pembrolizumab efficacy in endometrial cancer

Do you like it?0
Read more
28/03/2022
Published by Fondazione Gianni Bonadonna at 28/03/2022
Categories

Breast cancer, a mechanism to bypass anti-ER and anti-HER2 resistance

Do you like it?0
Read more
21/03/2022
Published by Fondazione Gianni Bonadonna at 21/03/2022
Categories

MEK inhibition enhances chemoimmunotherapy

Do you like it?0
Read more
123456
Next page
English